12Mar/100
Neoprobe says radioactive tracing agent’s NDA on track (Reuters)
Reuters - Diagnostics products maker Neoprobe Corp said U.S. health regulators have indicated that data from a late-stage trial of its radioactive tracing agent would support filing for marketing approval.